Biogen, Inc. (BIIB)
218.43
-3.72
(-1.67%)
USD |
NASDAQ |
Oct 08, 16:00
218.44
+0.01
(+0.00%)
After-Hours: 20:00
Biogen 30-Day Average Daily Volume : 1.014M for Oct. 8, 2026
30-Day Average Daily Volume Chart
Historical 30-Day Average Daily Volume Data
| Date | Value |
|---|---|
| October 08, 2026 | 1.014M |
| October 07, 2026 | 990716.3 |
| October 06, 2026 | 963957.5 |
| October 05, 2026 | 952015.2 |
| October 02, 2026 | 944382.8 |
| October 01, 2026 | 945322.7 |
| September 30, 2026 | 916370.1 |
| September 29, 2026 | 887726.1 |
| September 28, 2026 | 869594.9 |
| September 25, 2026 | 843677.4 |
| September 24, 2026 | 840412.9 |
| September 23, 2026 | 832236.2 |
| September 22, 2026 | 813647.7 |
| September 21, 2026 | 800117.1 |
| September 18, 2026 | 797183.9 |
| September 17, 2026 | 739073.4 |
| September 16, 2026 | 740309.2 |
| September 15, 2026 | 760282.9 |
| September 14, 2026 | 766447.8 |
| September 11, 2026 | 780858.7 |
| September 10, 2026 | 774771.4 |
| September 09, 2026 | 823555.8 |
| September 08, 2026 | 861472.8 |
| September 04, 2026 | 866297.8 |
| September 03, 2026 | 870673.3 |
| Date | Value |
|---|---|
| September 02, 2026 | 886717.5 |
| September 01, 2026 | 872486.4 |
| August 31, 2026 | 868064.5 |
| August 28, 2026 | 872467.3 |
| August 27, 2026 | 893594.0 |
| August 26, 2026 | 939435.8 |
| August 25, 2026 | 986769.6 |
| August 24, 2026 | 1.100M |
| August 21, 2026 | 1.154M |
| August 20, 2026 | 1.168M |
| August 19, 2026 | 1.196M |
| August 18, 2026 | 1.231M |
| August 17, 2026 | 1.247M |
| August 14, 2026 | 1.267M |
| August 13, 2026 | 1.287M |
| August 12, 2026 | 1.296M |
| August 11, 2026 | 1.306M |
| August 10, 2026 | 1.318M |
| August 07, 2026 | 1.373M |
| August 06, 2026 | 1.389M |
| August 05, 2026 | 1.405M |
| August 04, 2026 | 1.411M |
| August 03, 2026 | 1.426M |
| July 31, 2026 | 1.453M |
| July 30, 2026 | 1.451M |
30-Day Average Daily Volume Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
30-Day Average Daily Volume Benchmarks
| Ionis Pharmaceuticals, Inc. | 3.893M |
| AbbVie, Inc. | 4.415M |
| Gilead Sciences, Inc. | 5.591M |
| Regeneron Pharmaceuticals, Inc. | 720681.1 |
| Amgen, Inc. | 2.956M |